Novartis Q1 Core Earnings, Sales Rise; 2025 Outlook Set

MT Newswires Live
04-29

Novartis (NVS) reported Q1 core earnings Tuesday of $2.28 per diluted share, up from $1.80 a year earlier.

Analysts polled by FactSet expected $2.11.

Net sales to third parties for the quarter ended March 31 were $13.23 billion, up from $11.83 billion a year earlier.

Analysts surveyed by FactSet expected $13.08 billion.

The company said it expects full-year sales to grow in the high single digits and core operating income to grow in the low double digits.

Shares of the company rose more than 1% in recent Tuesday premarket activity.

Price: 114.05, Change: +1.42, Percent Change: +1.26

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10